Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone

about

Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone

Item

http://www.wikidata.org/entity/Q37739936

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone

@en

Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone.

@nl

type

Item

label

Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone

@en

Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone.

@nl

prefLabel

Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone

@en

Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone.

@nl

P1476

Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone

@en

P2093

Eugenia Prinzi

http://www.w3.org/2001/XMLSchema#string

Giovanni Corsello

http://www.w3.org/2001/XMLSchema#string

Maria Cristina Maggio

http://www.w3.org/2001/XMLSchema#string

Rolando Cimaz

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of Bullous Systemic Lupus Erythematosus

Bullous systemic lupus erythematosus.

Treatment of lupus with corticosteroids.

Lupus erythematosus: systemic and cutaneous manifestations.

Bullous dermatosis and systemic lupus erythematosus in a 15-year-old boy.

Retrospective Study on Autoimmune Blistering Disease in Paediatric Patients.

Bullous lupus: an unusual initial presentation of systemic lupus erythematosus in an adolescent girl.

Vincristine-cyclophosphamide combination therapy positively affects T-cell subset distribution in systemic lupus erythematosus patients.

Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.

[Three cases of bullous lupus erythematosus].

P304

317-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/AJCR.902351

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28352068

http://www.w3.org/2001/XMLSchema#string

P932

5383011

http://www.w3.org/2001/XMLSchema#string